Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001395064-25-000124
Filing Date
2025-08-08
Accepted
2025-08-07 20:51:50
Documents
2
Period of Report
2025-06-30
Effectiveness Date
2025-08-08

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2363
2 INFORMATION TABLE information_table.html INFORMATION TABLE  
2 INFORMATION TABLE information_table.xml INFORMATION TABLE 4904
  Complete submission text file 0001395064-25-000124.txt   8555
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)